Clinical Trial Update: A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is ongoing to assess the safety and efficacy of the RNDP-001 surgical implant in patients with Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RNDP-001

Snippet

Sponsor: Kenai Therapeutics | Conditions: Idiopathic Parkinson´s Disease, Parkinson's Disease | Phase 1, Phase 2 | Status: RECRUITING